Cannabidiol research for Epilepsy continues to be hindered by Drug Laws

Curtis Howell PURE CBD 0 Comments

Medical progress for cannabidiol treatments to prevent epilepsy continue to be derailed by drug laws according to a report by New England Journal of Medicine.

According to Daniel Friedman, MD, and Orrin Devinsky, MD, from the NYU Langone Medical Center in New York City a major brain receptor, cannabinoid receptor 1 or CB1, when activated, appears to have anticonvulsant effects. CB1 receptors are activated by tetrahydrocannabinol, the constituent in cannabis that is psychoactive. Animals studies have found that non-psychoactive Cannabidiol (CBD) gives best chance of preventing seizures.

To read more, check out “Cannabinoids in the Treatment of Epilepsy” at:

Brought to you by Visit our blog for more more news, information, and interesting facts about Cannabidiol (CBD).


New technology may enhance Hemp CBD Bioavailability
Could CBD company be teaming up with Hollywood and NFL with the movie “Concussion” starring Will Smith?
This news and information feed is provided as a convenience and does not imply any medical benefit or endorse any medical or other uses of  CBD PUR products.

Leave a Reply